GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension is a research paper published in Journal of Clinical Investigation (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R01HL164581,R01HL153915,T32HL007731,R01AG058659,K24HL174231,HL151552
Gates Cambridge Trust
Grant: OPP1144
NIHR
Grant: NIHR203321
VAORD grant
Grant: VA CX002011
CFF
Grant: HAYS19AB3
BHF
Grant: SP/12/12/29836,SP/18/10/33975
National Institutes of Health
Grant: 5T32HL007731-29
Molecular and Cellular Basis of Cardiovascular Disease
National Institutes of Health
Grant: 5K24HL174231-02
Molecular phenotypes of frailty in lung transplantation
National Institutes of Health
Grant: 5R01HL153915-04
Molecular pathogenesis of pulmonary arterial hypertension
National Institutes of Health
Grant: 5R01AG058659-03
A Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction
National Institutes of Health
Grant: 5R01HL164581-02
Elucidating the structural insights into the BMP receptor mutations in PAH
NHLBI NIH HHS
Grant: R01 HL153915
NHLBI NIH HHS
Grant: R01 HL164581
Fields of Study
MeSH Terms
Keywords